Robeco Institutional Asset Management B.V. Grows Stock Holdings in Danaher Corporation $DHR

Robeco Institutional Asset Management B.V. boosted its holdings in shares of Danaher Corporation (NYSE:DHR) by 161.2% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 175,724 shares of the conglomerate’s stock after purchasing an additional 108,448 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Danaher were worth $34,713,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of DHR. GHP Investment Advisors Inc. increased its position in Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after acquiring an additional 99 shares during the last quarter. Sierra Ocean LLC increased its position in Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after acquiring an additional 76 shares during the last quarter. Smallwood Wealth Investment Management LLC bought a new position in Danaher during the first quarter valued at $31,000. Dunhill Financial LLC increased its position in Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock valued at $34,000 after acquiring an additional 67 shares during the last quarter. Finally, Costello Asset Management INC bought a new position in Danaher during the first quarter valued at $41,000. Institutional investors own 79.05% of the company’s stock.

Insider Transactions at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 11.10% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

DHR has been the topic of a number of analyst reports. UBS Group cut their price objective on shares of Danaher from $240.00 to $225.00 and set a “buy” rating on the stock in a research report on Wednesday, July 23rd. Scotiabank upgraded shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price target on the stock in a report on Friday, July 11th. Guggenheim restated a “buy” rating and issued a $250.00 price target on shares of Danaher in a report on Wednesday, July 23rd. Evercore ISI cut their price target on shares of Danaher from $230.00 to $226.00 and set an “outperform” rating on the stock in a report on Tuesday, July 8th. Finally, Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a report on Friday, June 27th. Seventeen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $245.91.

Danaher Stock Up 2.2%

Shares of Danaher stock opened at $215.05 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.41. The firm’s 50-day moving average is $200.19 and its two-hundred day moving average is $197.42. The stock has a market cap of $153.98 billion, a price-to-earnings ratio of 45.75, a PEG ratio of 3.00 and a beta of 0.77.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company had revenue of $5.94 billion for the quarter, compared to analysts’ expectations of $5.83 billion. During the same period in the prior year, the business earned $1.72 EPS. The firm’s quarterly revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio is presently 27.23%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.